First hemophilia B gene therapy approved: More than two decades in the making

Simple item page
dc.contributor.authorHerzog, Roland W.
dc.contributor.authorVandenDriessche, Thierry
dc.contributor.authorOzelo, Margareth C.
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2024-05-22T15:24:43Z
dc.date.available2024-05-22T15:24:43Z
dc.date.issued2023
dc.eprint.versionFinal published version
dc.identifier.citationHerzog RW, VandenDriessche T, Ozelo MC. First hemophilia B gene therapy approved: More than two decades in the making. Mol Ther. 2023;31(1):1-2. doi:10.1016/j.ymthe.2022.12.001
dc.identifier.urihttps://hdl.handle.net/1805/40948
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.ymthe.2022.12.001
dc.relation.journalMolecular Therapy
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectFactor IX
dc.subjectFactor VIII
dc.subjectGenetic therapy
dc.subjectGenetic vectors
dc.subjectHemophilia A
dc.subjectHemophilia B
dc.titleFirst hemophilia B gene therapy approved: More than two decades in the making
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840138/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Herzog2023First-PP.pdf
Size:
178.92 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles